Home > PE Ratio > GENNEX LABORATORIES

GENNEX LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENNEX LABORATORIES is 16.06.

Share Price ₹12.3Feb 02,2026
Market Cap ₹299.7 Cr
Earnings-TTM₹18.7 CrTTM-Consolidated Results
Price/Earnings16.06xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
GENNEX LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENNEX LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENNEX LABORATORIES is calculated as :

Current Market Cap [ ₹299.7 Cr] as on Feb 02,2026

(/) Earnings [ ₹18.7 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 16.06x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENNEX LABORATORIES , the investors are currently willing to pay 16.06 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENNEX LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENNEX LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of GENNEX LABORATORIES


PE Ratio Performance Analysis for GENNEX LABORATORIES

- GENNEX LABORATORIES 's latest p/e ratio is 16.06x.

- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.31x.

- GENNEX LABORATORIES 's operated at median p/e ratio of 16x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 31.6x.

- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 11.69x.


How does GENNEX LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENNEX LABORATORIES 18.6616.06299.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4035.53390,828.0
DIVIS LABORATORIES LTD2,485.0063.67158,227.0
CIPLA LTD4,544.7023.32105,961.0
TORRENT PHARMACEUTICALS LTD2,140.0063.11135,045.0
DR REDDYS LABORATORIES LTD5,508.7017.9198,682.5
MANKIND PHARMA LTD1,767.0648.2985,330.9
ZYDUS LIFESCIENCES LTD4,973.4017.7988,473.1
LUPIN LTD4,347.5322.3797,270.2
AUROBINDO PHARMA LTD3,447.7519.8068,250.0
ABBOTT INDIA LTD1,508.9538.4758,046.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GENNEX LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 16.06x
Max industry PE 63.67x
Median industry PE 23.32x
Average industry PE 33.30x



You may also like the below Video Courses